lr rrp
TRANSCRIPT
-
8/17/2019 LR RRP
1/49
RECURRENT RESPIRATORY
PAPILLOMATOSIS
Presentant : Ichsan Juliansyah Juanda, dr.
Supervisor : Agung Dinasti Permana, dr., M.Kes.,Sp. TT!K" #K$
%torhinolaryngologyead and &ec' Surgery Departement
(aculty %) Medicine *&PADDr. asan Sadi'in +eneral ospital
-/
LITERATURE READING "A0I&+!(A0I&+
1
-
8/17/2019 LR RRP
2/49
I&T0%D*1TI%&
Most common benignneoplasm of the larynx amongchildren
– 2nd
most common cause ofpediatric hoarseness
Disease of viral etiology and
May involve entire
aerodigestive tract
Benign disease, Morbidity due
to airway involvement and risk
of malignant conversionByron ! Bailey, "ead # $eck %urgery&'tilaryngology, (th editon, )ippincot *illiams #
*ilkins, +hiladephia, 21-
2
-
8/17/2019 LR RRP
3/49
I&T0%D*1TI%&
Diagnosed at 2 and - years of age
delay from onset of symptoms
averaging about 1 year
.(/ of the children have been
diagnosed before their (th birthday
0hildhood uvenile onset recurrent
respiratory papillomatosis & '33+4
– more aggressive
5dulthood adult onset recurrent
respiratory papillomatosis& 5'33+4
Byron ! Bailey, "ead # $eck %urgery&'tilaryngology, (th editon, )ippincot *illiams #*ilkins, +hilade hia, 21-
6
-
8/17/2019 LR RRP
4/49
2PID2MI%"%+3
AD*"T %&S2T
+eaks 2&- yrs
%light male predominance )ess aggressive
(/ pts need 7 ( proceduresover their lifetime as opposed
to 72(/ of children who cansay the same
1I"D%%D %&S2T
'ften at 2&- yrs old
Boys 8 9irls $o gender:ethnicdi;erence
More aggressive 1
child -!- per year
-
-
8/17/2019 LR RRP
5/49
2TI%"%+3 #P4$
D$5 containing virus & ., and 11
• 5lso cause genital warts
=ype 11 appear to have a more
obstructive airway course early in the
disease and a greater need for
tracheotomy
'ther types identi?ed
=ype 1> and 1@ most malignant
potential4 Byron ! Bailey, "ead # $eck %urgery&'tilaryngology, (th editon,)ippincot *illiams # *ilkins, +hiladephia, 21-
(
-
8/17/2019 LR RRP
6/49
2TI%"%+3 • P4 In)ection Associated 5ith
+reater 00P Disease Severity
• P4 or P4 /6 1o!In) re7uiredmore surgical intervention
suggesting more severemani)estation
>
-
8/17/2019 LR RRP
7/49
2TI%"%+3 P4 in)ection process initiates in 8asal layer
4iral D&A enters the cell
D&A then transcri8ed into 0&A
0&A translated into viral proteins
Byron ! Bailey, "ead # $eck %urgery&'tilaryngology, (th editon, )ippincot *illiams # *ilkins, +hiladephia,21-
.
-
8/17/2019 LR RRP
8/49
2TI%"%+3 ost immune response compromised
Mal)unction o) cell mediatedresponse
Stealth li'e e9ect on immune
surveillance
"+A infection can be activelyepressed or latent
"+A D$5 detected in the
normal mucosa o) 00Ppatients
0eactivation can occur atany time
A%00P could be
– 5ctivation of latent virusacCuired since birth
– 5ctivation of infectioncontracted during adult life
@
-
8/17/2019 LR RRP
9/49
Pedunculated masses
5ith ;ngerli'e
pro
-
8/17/2019 LR RRP
10/49
MA10%S1%PI1
Sessile or pedunculated and irregular eophytic
clusters
Pin'ish to 5hite in coloration1
-
8/17/2019 LR RRP
11/49
2act mode o) transmission unclear
1hildhood onset lin'ed to mothers 5ith genital P4 in)ecti
Most li'ely to 8e ;rst 8orn, vaginally delivered to primigra
Adult!onset 00P possi8ly associated 5ith oral!genital cont
T0A&SMISSI%&
11
-
8/17/2019 LR RRP
12/49
T0A&SMISSI%&
5lthough there is close relationship between '33+ and maternal
condylomata, few patients exposed to genital warts at birth
manifest clinical symptoms
– &ot 5ell understood
Direct contact via the birth canal is the most likely method of
maternal&fetal transmission of "+A
– The ma-(–>(2
12
-
8/17/2019 LR RRP
13/49
Immunodeficiency Increases
Severity of RRP16
-
8/17/2019 LR RRP
14/49
"esion 1haracteristics
5ny site along aero&digestive track, most often occur at sites
where ciliated and sCuamous epithelium are uxtaposed
Most common 00P sites:
– )umen vestibuli
– $asopharyngeal surface of soft palate
– )aryngeal surface of epiglottis
– Fpper:lower margins of ventricle– Fndersurface of vocal folds
– 0arina
– Bronchial spurs
1-
-
8/17/2019 LR RRP
15/49
"esion 1haracteristics
Airal D$5 detected at normal mucosa recurrent after surgical
removal
Most common 00P condition:
– =racheostomiGed patient stoma and mid thoracic trachea
areas
where iatrogenic trauma to ciliated epithelium often induced
metaplasia4
– +rolonged == used alongside of the respiratory mucosa
– 93D risk factor for persistence of disease need additional
research
1(
-
8/17/2019 LR RRP
16/49+ruess et al! 5cta 'to&)aryngologica, 2.H 12. 11121
1>
-
8/17/2019 LR RRP
17/49
Patient immunity timing, length, and volume of virus
exposure4
"ocal traumas intubation, extra esophageal reIux4 must be
important in the development of 33+
+atients with 5'33+ had more li)etime seual partners and
a higher )re7uency o) oral se than matched controls
S21%&DA03 (A1T%0S1.
-
8/17/2019 LR RRP
18/49
1"I&I1A" (2AT*02S
allmar' triad:
– +rogressive hoarseness
– %tridor
– 3espiratory distress
Most often present with dysphonia
%tridor is usually 2nd symptom to manifest
Jnspiratory biphasic
0hronic cough, recurrent pneumonia, failure to thrive,
dyspnea, dysphagia may be present
%ometimes undiagnosed until respiratory distress result
1@
-
8/17/2019 LR RRP
19/49
00P >T2 +02AT
MAS?*20AD20@33+ often misdiagnosedas
Asthma
1roup
Tracheomalacia
Allergies
4ocal nodules
ronchitis
1<
-
8/17/2019 LR RRP
20/49
1"I&I1A" (2AT*02S
2tralaryngeal spread o) papillomas
– 16&6/ children and 1>/ adults
– Most freCuent sites
%ral cavity
Trachea
ronchi
Pulmonary
Dissemination
2
-
8/17/2019 LR RRP
21/49
PATI2&T ASS2SSM2&T
• 'nset of symptomsK• 3ate of progressionK
• 5ssociated infectionK
•
"ow is the cryK• +resence of respiratory distressK
• Luality of voice changeK Etiology
• "istory
• Air5ay trauma6 previous intu8ationB
Perinatal period
STD history
Parental condylomata6P4
21
4ocal cord nodules S 8 l tti t
-
8/17/2019 LR RRP
22/49
4oice characteristics
)ow&pitched, coarse, Iuttering voice 8 subglotticlesion
"igh&pitched, cracking, aphonic, or breathy 8glottic lesion "oarseness 5)*5N% indicates someabnormality in structure:function
$eonates 05$ present with papillomatosis
C 4ocal cord nodulesC Tracheomalacia #stridor since8irth$C 4ocal cord paralysis
C Su8glottic cystsC Su8glottichemangiomaC Su8glottic stenosis
Alternative Diagnosis to thin'a8out:
22
-
8/17/2019 LR RRP
23/49
PATI2&T ASS2SM2&T
Physical 2am– 3espiratory rate:degree of distress
$asal ala Iaring
Fse of accessory neck # chest muscles
– 1yanosis6air hunger
0hild may be sitting with hyperextended neck
Jf child is very sick, examination should beperformed in setting where resuscitation: endoscopiceCuipment and possible tracheotomy is 35DJ)Navailable i!e! '3, 3, J0F4
26
-
8/17/2019 LR RRP
24/49
P3SI1A" 2AMI&ATI%&
– 5uscultation of airway with stethoscope
– 5irway endoscopy needed for de?nitive diagnosis
Olexible ?beroptic consider +5=J$=
cooperation4, smallest P 1!< mm, seCuentialvideo
xam under anesthesia esp! if patient wonQtcooperate4
2-
-
8/17/2019 LR RRP
25/49
2AMI&ATI%&
$ormal 3espiratory cycle Shorter inspiratory, longer
epiratory
%tridor of laryngeal origin Inspiratory, progress to
8iphasic as air5ay narro5ing progress
+laced on various position to elicit any chages on
stridor &o changes 00P usually
'xygen saturation should be observed
+ulmonary testing *here asthma is likely diagnosis
Blood gas analysis
2(
-
8/17/2019 LR RRP
26/49
MA"I+&A&T T0A&S(%0MATI%&
1&./ of patients with 33+
5dvanced disease, usually pulmonary extension
6rd or -th decade of life
)esions contain "+A type 11 and type >
+erien et al
5verage duration to malignant transformation 1
-
8/17/2019 LR RRP
27/49
T02ATM2&T M%DA"ITI2S
Surgical
–
Microlaryngoscopy with cups forceps removal
– Microdebrider
– 0'2 laser
– +hono&Microsurgical
– E=+:$dN59 laser
– Olash scan lasers
Ad
-
8/17/2019 LR RRP
28/49
2@
-
8/17/2019 LR RRP
29/49
2<
-
8/17/2019 LR RRP
30/49
6
-
8/17/2019 LR RRP
31/49
E ours post operative painF 4oice ?uality post operative
The choice to use microde8rider vs. 1% laser not onlydepends upon the a)orementioned )actors #cost,procedure time, pain, etc.$ 8ut also, the characteristicso) the lesions
61
-
8/17/2019 LR RRP
32/49
021*002&T 02SPI0AT%03PAPI""%MAT%SIS STA+I&+
5ssess)unctionalparameters,
Diagrammatically catalogssu8siteinvolvement
5ssigns a ?nalnumeric score to the patientTs
current etento) disease
StagingSystem
62
-
8/17/2019 LR RRP
33/49
ADJ*4A&T T20API2S
5pproximately 2/ need some formof aduvant therapy
0riteria • U - surgical procedure:year• Distal or metastatic disease• 3apid re&growth of papilloma with
airway compromised
66
-
8/17/2019 LR RRP
34/49
6-
-
8/17/2019 LR RRP
35/49
1ID%(%4I0
;ectiveness in intra&lesional route 3oute
Jnection of (mg:m) into papilloma bed
Microbedding total volume 2 m)
3epeating at -&> week intervals up to > months
vidence
0hadha 0omplete vs +artial response (./ vs 6(/4
McMurray $o statistical di;erence %ide ;ect 5nimal %tudies4
Malignant dysplasia of intra&lesional site
$ephrotoxicity and Mamary 5denocarcinoma
)indsay $o Malignant transformation in human
6(
-
8/17/2019 LR RRP
36/49
6>
-
8/17/2019 LR RRP
37/49
6.
-
8/17/2019 LR RRP
38/49
6@
-
8/17/2019 LR RRP
39/49
6<
-
8/17/2019 LR RRP
40/49
-
-
8/17/2019 LR RRP
41/49
-1
0ecom8inant )usion protein derived :
-
8/17/2019 LR RRP
42/49
sp2G
5ctivity has been demonstrated in genital 5art
treatment
0linical responses observed in P4 / ! negative
lesions
+ediatric patients improving clinical course
Derkay, 2(4
2. patients #H (, E M$ aged 2&1@ years old
5fter baseline de8ul'ing surgery sp2G
--g subseCuently monthly for H doses over /-
days
0ecom8inant )usion protein derived :
M. Bovis 1+ heat shoc' protein /#sp/$
2G protein o) P4 /
-2
-
8/17/2019 LR RRP
43/49
P4 4accine
4A11I&2S A4AI"A"2
+ardasil #Merc'$
Luadrivalent
1ervari #+laoSmithKline$
Bivalent
Phase II trials have demonstrated ecellent sa)ety without
maor side&e;ects
Phase III trials have shown e9ective prevention o) genital
5art epression and progression to 0J$ JJ:JJJ
-6
-
8/17/2019 LR RRP
44/49
--
-
8/17/2019 LR RRP
45/49
ighlights
• 33+ is a )rustrating, captous disease with the potential
)or mor8id conseCuences due to its involvement o) the
air5ay and the ris' o) malignant trans)ormation!
• &o single modality o) therapy shown e;ective, goals of
surgical therapy a sa)e air5ay
• Many ad
-
8/17/2019 LR RRP
46/49
TA&K 3%*
->
-
8/17/2019 LR RRP
47/49
"J%='3N %ir Morrell MackenGie 1@6.&1@
-
8/17/2019 LR RRP
48/49
sexuallytransmitteddisease in humans
1- million women,or about 1/ ofthe femalepopulation of child&bearing age are
D$5 positive buthave no visiblelesions while morethan @ millionwomen, or >/ ofthe at riskpopulation, are"+A antibodypositive but D$5negative
0linically apparent"+A infection has
-@
-
8/17/2019 LR RRP
49/49
0esarean %ection KK
%eems to be an obvious risk reducerfor 33+ transmission, but
– "igher morbidity and mortality for
the mother
– "igher cost compared to vaginal delivery
– 5pprox! 1 in - children delivered
vaginally to mothers with active
condylomatous lesions will contract
33+
– Oew cases have reported in utero
development of the disease
-